Does alfacalcidol reduce cardiovascular complications in hemodialysis patients?
- 1 April 2019
- journal article
- editorial
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (8), 167
- https://doi.org/10.21037/atm.2019.03.26
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Impaired Vitamin D Metabolism in CKDSeminars in Nephrology, 2013
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23Journal of the American College of Cardiology, 2012
- VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH <=150 pg/mL: results of the Italian FARO SurveyNephrology Dialysis Transplantation, 2012
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJAMA, 2012
- Therapeutic Effects of Vitamin D Analogs on Cardiac Hypertrophy in Spontaneously Hypertensive RatsThe American Journal of Pathology, 2010
- Vitamin D Receptor Activators Can Protect against Vascular CalcificationJournal of the American Society of Nephrology, 2008
- Japanese Society of Dialysis Therapy Treatment Guidelines for Secondary HyperparathyroidismTherapeutic Apheresis and Dialysis, 2007
- Differential effects of vitamin D receptor activators on vascular calcification in uremic ratsKidney International, 2007
- Genetics and biology of vitamin D receptor polymorphismsGene, 2004
- Association of Comorbid Conditions and Mortality in Hemodialysis Patients in Europe, Japan, and the United StatesJournal of the American Society of Nephrology, 2003